SCHEMBL13145482

SCHEMBL13145482

CC(C)c1occc1CCOCc1ccccc1

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.41
TDP1 Q9NUW8 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
LMNA P02545 1/20 0.36
GAA P10253 1/20 0.36
KCNA3 P22001 3/20 0.36
KCNA5 P22460 3/20 0.36
KCNA1 Q09470 1/20 0.36
NAAA Q02083 1/20 0.35
HTT P42858 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
HRH4 Q9H3N8 1/20 0.35
HRH3 Q9Y5N1 1/20 0.35
ALDH1A1 P00352 2/20 0.34
CA1 P00915 2/20 0.34
CA2 P00918 2/20 0.34
CA7 P43166 2/20 0.34
CA9 Q16790 2/20 0.34
KMT2A Q03164 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13756761 0.86 TSHR (0.50) TSHRTDP1L3MBTL1LMNAGAA
SCHEMBL13180110 0.81 GAA (0.48) TSHRTDP1L3MBTL1LMNAGAA
SCHEMBL11716752 0.72 KMT2A (0.47) TSHRTDP1L3MBTL1LMNAKCNA3
SCHEMBL13145274 0.72 TSHR (0.40) TSHRTDP1L3MBTL1NAAAHTT
SCHEMBL1066576 0.70 TSHR (0.67) TSHRTDP1L3MBTL1NAAASMN1; SMN2
SCHEMBL13145286 0.70 TDP1 (0.41) TSHRTDP1L3MBTL1NAAAHTT
SCHEMBL13763148 0.69 TSHR (0.54) TSHRTDP1L3MBTL1LMNAGAA
SCHEMBL13145294 0.69 TDP1 (0.40) TSHRTDP1L3MBTL1GAANAAA
Water SCHEMBL28780406 0.68 TSHR (0.64) TSHRTDP1L3MBTL1NAAAHRH4
Hydrochloric Acid SCHEMBL1409425 0.68 TSHR (0.64) TSHRTDP1L3MBTL1NAAAHRH4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7795261-B2 Substituted 1-piperidin-4-yl-4-pyrrolidin-3-yl-piperazine derivatives and their use as neurokinin antagonists JANSSEN PHARMACEUTICA NV (BE) 2010-09-14 US disclosed